Results: 7

Taxane-induced scleroderma: report of two cases

Rev. méd. Chile; 149 (5), 2021
ABSTRACT Taxanes are a class of chemotherapeutic agents with common associated dermatologic adverse events, such as skin hyperpigmentation, hand-foot skin syndrome, paronychia and onycholysis. Taxane-induced scleroderma is rare. Few cases with skin findings resembling systemic sclerosis, have been report...

Evolución del índice de actividad en pacientes con esclerosis sistémica tratados con ciclofosfamida y prednisona
Evolution of the index of activity in patients with systemic sclerosis treated with cyclophosphamide and prednisone

Rev. cuba. reumatol; 23 (1), 2021
Introducción: La esclerosis sistémica es una enfermedad autoinmune del tejido conectivo donde ocurre inicialmente la vasculopatía y persiste durante toda la enfermedad. El índice de actividad revela un periodo crítico de la enfermedad. Objetivo: Evaluar la evolución clínica del índice de activ...

Is rituximab effective for systemic sclerosis? A systematic review and meta-analysis

Adv Rheumatol; 61 (), 2021
Abstract Background: Systemic sclerosis (SSc) Is a clinically complex and challenging disease, that leads to skin fibrosis. Its most frequent complication is interstitial lung disease (ILD), which leads to a worse prognosis. In this situation, cyclophosphamide is considered the gold standard for its tre...

Comparação do Escore de Rodnan modificado e durômetro em pacientes com esclerose sistêmica difusa

esclerose sistêmica é uma enfermidade autoimune, causadora de danos vasculares e fibroses. É dentre as doenças de sistema conjuntivo, bem conhecida, devido à alta mortalidade, principalmente pelas causas pulmonares e cardíacas. Para a avaliação do tecido cutâneo de portadores de esclerose sistê...

Nephrotic syndrome as the first manifestation of juvenile systemic scleroderma

Rev. bras. reumatol; 57 (6), 2017

Rituximab for the therapy of systemic sclerosis: a series of 10 cases in a single center

Rev. bras. reumatol; 56 (5), 2016
Abstract Systemic sclerosis (SSc) is a chronic autoimmune disease with a high morbidity and mortality. Although cyclophosphamide is effective for severe and refractory cases, there is demand for new treatments. The biological treatment with B-cell depletion with rituximab (RTX) has demonstrated efficacy ...

Tiempo de depuración esofágica de Bario (TIDEB): una nueva técnica en la evaluación de disfunción esofágica en pacientes con esclerosis sistémica progresiva

Trabajo realizado en el Hospital Arzobispo Loayza (Lima) entre 1985-1987, dentro de un protocolo de estudio a doble ciego de 5 fluorouracilo en el tratamiento de esclerosis sistémica progresiva (ESP). El objetivo fue evaluar en forma prospectiva las alteraciones inducidas por ESP en la motilidad esofág...